Gilead Partners with PEPFAR to Provide Twice-Yearly HIV Prevention to 2 Million People in Low-Income Countries Read more
Amgen to Invest Over $600 Million in New Science and Innovation Center at U.S. Headquarters Read more
Boehringer’s HERNEXEOS Approved in China as First Oral Targeted Therapy for HER2-Mutant Advanced NSCLC Read more
Lilly’s Oral GLP-1, Orforglipron, Succeeds in Third Phase 3 Trial, Paving Way for Global Obesity Filings Read more